Results for plasmodium translation from English to Chinese (Simplified)

plasmodium
疟原虫属

plasmodium berghei
伯氏疟原虫

plasmodium vivax malaria
疟原虫病

morocco reported its last case of indigenous plasmodium vivax malaria transmission in 2004.
摩洛哥报告的最后一例本地传播的间日疟原虫性疟疾病例是在2004年。

19. dipstick diagnostic tests for plasmodium falciparum have been developed by the private sector.
19. 私人部门还对恶性疟原虫进行dipstick诊断试验。

in 2009, the european region reported no cases of plasmodium falciparum malaria for the first time.
2009年欧洲区域首次报告未发现恶性疟原虫疟疾病例。

43. the first evidence of plasmodium falciparum resistance to artemisinin in western cambodia was published in 2008.
43. 2008年公布了在柬埔寨西部发现的第一例恶性疟原虫疟疾对青蒿素抗药性的证据。

49. the first documented evidence of plasmodium falciparum resistance to artemisinin in western cambodia was published in 2008.
49. 2008年公布了在柬埔寨西部发现的第一例恶性疟对青蒿素抗药性的书面证据。

cambodia national surveillance data have also confirmed that the number of cases of plasmodium falciparum malaria in the target areas has fallen dramatically.
柬埔寨的全国监测数据也证实，目标地区的恶性疟病例数大幅度减少了。

of these, saudi arabia is the only country that still has active plasmodium falciparum transmission and that is located outside the palearctic ecozone.
在这些国家中，沙特阿拉伯是唯一一个仍有活动性恶性疟传播的国家，也是唯一一个位于古北区经济区之外的国家。

14. artemisinin combination therapies not only are efficacious, but also help to prevent the emergence and spread of drug-resistant plasmodium.
14. 青蒿素综合疗法不仅有效，而且还有助于防止抗药性疟原虫的出现和传播。

the one most extensively studied clinically is spf-66, against plasmodium falciparum, which was developed in colombia and donated to who.
临床上最广泛研究的一种疫苗是抗恶性疟原虫spf-66，这种疫苗由哥伦比亚研制并捐赠给卫生组织。

however, there are concerning data to suggest that foci of artemisinin-resistant plasmodium falciparum may have emerged in other sites in the mekong subregion.
但是，有关数据表明，湄公河次区域的其他地点可能已出现对青蒿素具有抗药性的恶性疟原虫疟疾疫源地，这令人关切。

12. over half of the approximately 50 million women who become pregnant in malaria-endemic countries each year live in tropical areas of africa with intense transmission of plasmodium falciparum.
12. 在疟疾流行国家每年怀孕的大约5 000万妇女，有一半以上生活在恶性疟原虫密集传播的非洲热带地区。

15. the global malaria situation is threatened by the increasing resistance of plasmodium falciparum to conventional antimalarial medicines, such as chloroquine, sulfadoxine-pyrimethamine and amodiaquine.
15. 恶性疟原虫对常规抗疟药物如氯喹、周效磺胺和氨酚喹的抗药性增强使得全球疟疾状况受到了威胁。

(a) the resistance of malaria plasmodium to some of the antimalarial drugs, even with the so-called combination therapy method of treatment;
(a) 疟原虫对一些抗疟疾药物的耐药性，即使使用了所谓的联合疗法；

37. by 2009, 77 of 86 plasmodium falciparum malaria-endemic countries and territories had adopted artemisinin-based combination therapies for use as part of their national drug policies.
37. 截至2009年，在86个恶性疟原虫疟疾流行的国家和领土中已有77个在其境内药物政策中采用了青蒿素综合疗法。

13. confirmed cases of plasmodium falciparum malaria without complications should be treated with an artemisinin combination therapy, and plasmodium vivax malaria should be treated with chloroquine where it is effective, or with an appropriate artemisinin combination therapy in areas where plasmodium vivax is resistant to chloroquine.
13. 应采用青蒿素综合疗法来治疗无并发症恶性疟原虫疟疾的确诊病例，当氯喹有效时就用氯喹来治疗间日疟，在间日疟对氯喹产生抗药性的地区可采用适当的青蒿素综合疗法。

13. confirmed cases of plasmodium falciparum malaria without complications should be treated with an artemisinin-based combination therapy, and cases of plasmodium vivax should be treated with chloroquine in areas where it is effective, or with an appropriate artemisinin-based combination therapy in areas where the resistance of plasmodium vivax to chloroquine has been documented.
13. 应采用青蒿素综合疗法来治疗无并发症恶性疟原虫疟疾的确诊病例，在氯喹有效的地区用氯喹来治疗间日疟病例，在间日疟对氯喹产生抗药性的地区可采用适当的青蒿素综合疗法。